Flu Season Alert!Alerta de temporada de influenza:
Don’t let germs win this season – protect yourself and your family!
The flu vaccine is your best defense against flu and related complications – PLUS, it is a covered benefit for Texas Children’s Health Plan members! Learn more!
¡No permitas que los gérmenes ganen esta temporada! ¡Protégete a ti y a tu familia!
La vacuna contra la influenza es tu mejor defensa contra la influenza y sus complicaciones. Además, ¡es un beneficio cubierto para los miembros de Texas Children's Health Plan! Aprende más
Change in Preferred Drug List Status for Intranasal Rhinitis Agents
Date: September 30, 2025
Attention: All Providers
Effective date: September 29, 2025
Call to action: Texas Children’s Health Plan (TCHP) would like to inform providers that effective September 29, 2025, the Texas Health and Human Services Commission (HHSC) removed non-preferred status from generic azelastine/fluticasone nasal products on the preferred drug list (PDL). This change is in response to a shortage brand Dymista products.
Impacted Medication
Type of Change
Effective Date
AZELASTINE/FLUTICASONE 137-50MCG SPR
Generic now preferred
September 29, 2025
How this impacts providers: The change will allow providers to prescribe the generic without requiring PDL prior authorization at this time and continue accessing necessary medication for their patients.
Next step for providers: Prescribers are encouraged to proactively obtain a prescription for the preferred alternatives to avoid disruption in patient’s therapy. Prescribers should share this communication with their staff.
